360° SearchNetwork Hot Spots Trends Time Series

Ivabradine

Type: Product

Name: Ivabradine

First reported Apr 17 2013 - Updated Apr 17 2013 - 1 reports

Dronedarone's Inhibition of If Current Is the Primary Mechanism Responsible for its Bradycardic Effect

The mechanism(s) whereby dronedarone reduces sinus rate are not well understood, although L‐type calcium channel antagonism, beta‐adrenergic blockade, and inhibition of If are plausible.Methods and ResultsIn anesthetized pigs, we compared effects of dronedarone ... [Published Bionity.com - Apr 17 2013]

Entities: Dronedarone, Ivabradine, Calcium, Isoproterenol, Diltiazem

First reported Apr 15 2013 - Updated Apr 15 2013 - 1 reports

Human medicines European Public Assessment Report (EPAR): Procoralan, ivabradine, Revision: 10, Authorised

[Published Pending EC decisions and European Public Assess ... - Apr 15 2013]

Entities: Procoralan, Ivabradine

First reported Apr 12 2013 - Updated Apr 12 2013 - 1 reports

Human medicines European Public Assessment Report (EPAR): Corlentor, ivabradine, Revision: 10, Authorised

[Published Pending EC decisions and European Public Assess ... - Apr 12 2013]

Entities: Ivabradine

First reported Nov 28 2012 - Updated Nov 28 2012 - 1 reports

NHS

Ivabradine gets green light from NICE for chronic heart failure

Ivabradine has been endorsed for NHS use in England and Wales for its chronic heart failure indication... Original Article ... [Published BioPortfolio - Nov 28 2012]

Entities: Ivabradine, congestive heart failure, NHS, Wales

First reported Nov 28 2012 - Updated Nov 28 2012 - 2 reports

NICE approves drug for treatment of chronic heart failure

GPs with a specialist interest in heart failure and other healthcare professionals can now use ivabradine (Procoralan) as an option for the treatment of people with chronic heart failure, following latest guidance from NICE. ... [Published NICE | National Institute for Health and Clinic ... - Nov 28 2012]

Entities: congestive heart failure, Procoralan, Ivabradine

More Content

sort by: Date \| Relevance
Dronedarone's Inhibition of If Current Is the P... [Published Bionity.com - Apr 17 2013]
Human medicines European Public Assessment Repo... [Published Pending EC decisions and European Public Assess ... - Apr 15 2013]
Human medicines European Public Assessment Repo... [Published Pending EC decisions and European Public Assess ... - Apr 12 2013]
Ivabradine gets green light from NICE for chron... [Published BioPortfolio - Nov 28 2012]
NICE approves drug for treatment of chronic hea... [Published NICE \| National Institute for Health and Clinic ... - Nov 28 2012]
NICE guidance recommends new treatment for some... [Published NICE \| National Institute for Health and Clinic ... - Nov 28 2012]

Blogs

sort by: Date \| Relevance
Human medicines European Public Assessment Repo... [Published Pending EC decisions and European Public Assess ... - Apr 15 2013]
Human medicines European Public Assessment Repo... [Published Pending EC decisions and European Public Assess ... - Apr 12 2013]
NICE approves drug for treatment of chronic hea... [Published NICE \| National Institute for Health and Clinic ... - Nov 28 2012] GPs with a specialist interest in heart failure and other healthcare professionals can now use ivabradine (Procoralan) as an option for the treatment of people with chronic heart failure, following latest guidance from NICE. ...
NICE guidance recommends new treatment for some... [Published NICE \| National Institute for Health and Clinic ... - Nov 28 2012] NICE has published guidance recommending ivabradine (Procoralan, Servier Laboratories) as an option for the treatment of some people with chronic heart failure. ...